Advertisement
U.S. Markets closed
S&P Futures
5,892.00 -4.25 (-0.07%) Dow Futures
43,140.00 -37.00 (-0.09%) Nasdaq Futures
20,499.50 -20.00 (-0.10%) Russell 2000 Futures
2,251.70 -3.80 (-0.17%) Crude Oil
70.54 -0.02 (-0.03%) Gold
2,737.70 -1.20 (-0.04%)
Newron Pharmaceuticals S.p.A. (NWRN.SW)
Swiss - Swiss Delayed Price. Currency in CHF
Follow
At close: 05:31PM CEST
| Previous Close | 8.98 |
| Open | 9.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 8.70 - 9.49 |
| 52 Week Range | 4.09 - 11.20 |
| Volume | |
| Avg. Volume | 52,792 |
| Market Cap | 172.317M |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.97 |
| Earnings Date | Sep 19, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.34 |
Business WireNewron presents H1 2024 results and provides business update
MILAN, September 19, 2024--Newron today announces its financial and operational results for the half year ended June 30, 2024, and provides an update on its business activities
GlobeNewswireAligos Therapeutics Strengthens Board with Two New Independent Directors
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced the appointment of Heather Preston, M.D. and Margarita Chavez, J.D. as Class II Independent Directors to the Board of Directors, effective August 7, 2024. Dr. Preston will join the Nominating and Corporate Gove
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.